Signal Says Take Profits on This Pharma Stock

ICPT stock could be on the cusp of a short-term pullback, if history is any guide

Dec 14, 2018 at 10:40 AM
facebook twitter linkedin


Intercept Pharmaceuticals Inc (NASDAQ:ICPT) stock has handily outperformed the broader equities market in 2018, up 83% year-to-date. However, the shares of ICPT recently flashed what's been a historical sell signal, suggesting now may be time for bulls to take profits -- or perhaps pick up some short-term options insurance.

Specifically, the drug stock is back within one standard deviation of its 160-week moving average, after a lengthy stretch below this trendline. There have been just three signals of this kind in the past, after which ICPT stock was lower three months later each time, averaging a loss of more than 13%, per data from Schaeffer's Senior Quantitative Analyst Rocky White. From the equity's current perch around $106.12, a similar pullback would put ICPT around $92.32.

Further, after more than doubling off its Feb. 9 low of $51.05, the pharmaceuticals stock is staring up at a familiar roadblock in the $120-$130 neighborhood. This area has acted as a ceiling for ICPT since late 2016, and the December 120 strike is home to peak call open interest in the front-month series, which could translate into an added options-related speed bump in the near term.

ICPT stock chart dec 14

Should the stock once again backpedal, several analysts could be caught off-guard. Intercept Pharmaceuticals boasts eight "strong buys" and one "buy" rating, compared to three lukewarm "holds" and just one "sell."

ICPT shareholders concerned about a short-term pullback could consider protective puts on the equity. The January 100 put, for instance, is currently asked at $7.30. Buying the puts to open would allow the shareholders to sell ICPT at $100 -- and likely lock in profits -- should the security take a tumble beneath the century mark before the options expire on Friday, Jan. 18.

 

Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

 
Schaeffer's Daily Bulletin Offer
 


 


 
Special Offers from Schaeffer's Trading Partners